EpiVax on Facebook
@EpiVax
RSS
March 2010
Faster, safer vaccines for a nation at risk
Faster, Safer Biodefense Vaccine Design for Department of Defense Vaccine Programs, as proposed by EpiVax, Inc. A Rhode Island Biotechnology Company http://www.EpiVax.com
February 2010
The best animal rule is no animal rule: correlates and determinants of immunogenicity
I love the words “species neutral”. Those two words conjure up Avatar-like non-humans with alluring physiognomy that is mid point between species, a topic that is probably more interesting to most of my readers than the real topic of this short essay . . .Sugar or Splice - Thoughts about Tregitopes and IVIG
Those who wish to further explain the myriad properties of intravenous immunoglobulin (IVIG) would do well to bear Tregitopes in mind.F is for Faster vaccines! and for Flu . . .
. . . having adequate supplies of appropriate medical countermeasures; quickly distributing those countermeasures; protecting the well through vaccines and prophylactic medications, environmental cleanup. According to the WMD report card, “the United States is seriously lacking in each of these vital capabilities”. Hence the failing grade of F.
Science for Ransom - why we don't pay to speak
OK, we’ve made our full disclosure. We don’t pay to speak. Now . . . It’s up to you. You’ve paid to attend. You deserve it. Ask the commercial conference company for the full Monty. Ask them to put the prices on the agenda. Find out which speaker is lobbying you, rather than sharing good science.The Futuroscope: Does the presence of Tregitopes correlate with antibody immunogenicity?
In this very brief update, we take a look at two monoclonal antibodies, Rituximab and Ofatumumab, and we compare and contrast their predicted (and observed) immunogenicity based on T cell epitope and Tregitope content. Taking out our Immunogenicity Futuroscope, we give an A+ to the Ofatumumab antibody.A very GAIA idea - a globally accessible, globally relevant HIV / AIDS Vaccine
There appears to be no limit to innovative ideas at the EpiVax biotechnology company. In fact, the GAIA...